Page last updated: 2024-11-10

glucitol hexanicotinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

glucitol hexanicotinate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3058386
CHEMBL ID4297070
CHEBI ID135889
SCHEMBL ID4450782
MeSH IDM0064374

Synonyms (24)

Synonym
CHEBI:135889
sorbinicate
2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)hexyl pyridine-3-carboxylate
[(2r,3r,4r,5s)-2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)hexyl] pyridine-3-carboxylate
38y76163xt ,
sorbinicate [inn]
lg 10017
sorbinicato [inn-spanish]
einecs 228-230-9
d-glucitol hexanicotinate
sorbinicato
unii-38y76163xt
sorbinicatum
glucitol hexanicotinate
sorbinicatum [inn-latin]
nicotinic acid, hexaester with d-glucitol
sorbinicate [who-dd]
d-glucitol, 1,2,3,4,5,6-hexa-3-pyridinecarboxylate
SCHEMBL4450782
sorbitol hexanicotinate
(2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexayl hexanicotinate
Q27256828
CHEMBL4297070
AKOS040747490

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" By modulating the bioavailability of nicotinic acid, sorbinicate maintains and in some cases enhances the pharmacological activity of the acid, avoiding at least some of its major side effects."( Comparative evaluation of some pharmacological properties and side effects of D-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acid.
Biagi, M; Sardelli, G; Schiantarelli, P; Subissi, A, 1980
)
0.26

Dosage Studied

ExcerptRelevanceReference
"Absorption, distribution and excretion of 14C-D-glucitol hexanicotinate (sorbinicate, SN) were studied after oral dosing in the rat against 14C-nicotinic acid (NA)."( On the absorption, distribution and excretion of sorbinicate in the rat and the monkey.
Bramanti, G; Criscuoli, M; Giachetti, C; Mondino, A; Silvestri, S; Subissi, A; Zanolo, G, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
aromatic carboxylic acidAny carboxylic acid in which the carboxy group is directly bonded to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (11.76%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]